Live from the NIH registry
Studies recruiting near Rock Hill right now
Top 25 of 601 recruiting studies, sorted by proximity — each links to its official registry page
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Carolinas Medical Center/Levine Children's Hospital (Adults and Pediatrics) — Charlotte, North Carolina (22.2 mi)
· Sponsor: Pierre Fabre Medicament
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Novant Health Presbyterian Medical Center — Charlotte, North Carolina (22.2 mi)
· Sponsor: SWOG Cancer Research Network
Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients
Pediatric Cancer
Phase 2
Interventional 64 participants sought
Levine Cancer Institute — Charlotte, North Carolina (22.2 mi)
· Sponsor: Wake Forest University Health Sciences
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
Chronic Lymphocytic Leukaemia, Moderate to Severe Cardiac Impairment
Phase 4
Interventional 60 participants sought
Research Site — Charlotte, North Carolina (22.2 mi)
· Sponsor: AstraZeneca
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Charlotte, North Carolina (22.2 mi)
· Sponsor: Sameek Roychowdhury
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Digestive Disease Associates — Rock Hill, South Carolina (1.2 mi)
· Sponsor: Janssen Research & Development, LLC
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Renal Cell Carcinoma
Phase 3
Interventional 904 participants sought
Carolina Oncology Specialists, PA ( Site 9002) — Charlotte, North Carolina (22.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
Severe Asthma
Phase 2
Interventional 512 participants sought
Research site — Rock Hill, South Carolina (1.2 mi)
· Sponsor: Kinaset Therapeutics Inc
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Charlotte, North Carolina (22.2 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
Post Operative Surgical Site Infection
Phase 3
Interventional 600 participants sought
Atrium Health Carolinas Medical Center — Charlotte, North Carolina (22.2 mi)
· Sponsor: Major Extremity Trauma Research Consortium
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia (CLL)
Phase 2
Interventional 75 participants sought
Novant Health Presbyterian Medical Center /ID# 230201 — Charlotte, North Carolina (22.2 mi)
· Sponsor: AbbVie
Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth in/Near Infected Bone Cavities
Periprosthetic Joint Infections
N/A
Interventional 204 participants sought
OrthoCarolina — Charlotte, North Carolina (22.2 mi)
· Sponsor: Elute, Inc.
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Carolinas Medical Center/Levine Cancer Institute — Charlotte, North Carolina (22.2 mi)
· Sponsor: Children's Oncology Group
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50238 — Charlotte, North Carolina (22.2 mi)
· Sponsor: UCB Biopharma SRL
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Levine Cancer Institute-Rock Hill — Rock Hill, South Carolina (1.2 mi)
· Sponsor: NRG Oncology
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Novant Health Cancer Institute — Charlotte, North Carolina (22.2 mi)
· Sponsor: Hoffmann-La Roche
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Charlotte, North Carolina (22.2 mi)
· Sponsor: AstraZeneca
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Carcinoma, Non-small-Cell Lung
Phase 2
Interventional 520 participants sought
Novant Health 1 — Charlotte, North Carolina (22.2 mi)
· Sponsor: Janssen Research & Development, LLC
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
OnSite Clinical Solutions, LLC — Charlotte, North Carolina (22.2 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Transthyretin Amyloidosis With Cardiomyopathy
Phase 3
Interventional 1,750 participants sought
Clinical Trial Site — Charlotte, North Carolina (22.2 mi)
· Sponsor: Alnylam Pharmaceuticals
Individualizing Treatment for Asthma in Primary Care (Full Study)
Asthma, Asthma Attack
Phase 4
Interventional 3,200 participants sought
Atrium Health — Charlotte, North Carolina (22.2 mi)
· Sponsor: DARTNet Institute
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Levine Cancer Institute — Charlotte, North Carolina (22.2 mi)
· Sponsor: Eli Lilly and Company
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
Delricht Clinical Research - Badmus — Charlotte, North Carolina (22.2 mi)
· Sponsor: Ardelyx
A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury
Traumatic Brain Injury
N/A
Observational 2,000 participants sought
Atrium Health - Carolina Medical Center — Charlotte, North Carolina (22.2 mi)
· Sponsor: Hoffmann-La Roche
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Neuroblastoma
Phase 2
Interventional 500 participants sought
Levine Children's Hospital — Charlotte, North Carolina (22.2 mi)
· Sponsor: Giselle Sholler